A 32-year-old man presents to the physical therapy clinic for his initial evaluation following a right knee anterior cruciate ligament (ACL) reconstruction. For the past four weeks, his right lower extremity has been immobilized in a rigid extension brace, and he has been strictly non-weight-bearing. On physical examination, the surgical incisions are well-healed without erythema or discharge. However, the circumference of his right mid-thigh is 4.5 cm less than that of his left mid-thigh. He reports no pain or paresthesias in the limb. Which of the following intracellular processes is primarily responsible for the macroscopic changes observed in this patient's right lower extremity?
- Covalent attachment of ubiquitin to cytoskeletal proteinsAnswer
- BRelease of cytochrome c from the mitochondrial intermembrane space
- CMassive influx of extracellular calcium across the plasma membrane
- DTransformation of mature skeletal muscle cells into adipocytes
- EFailure of the ATP-dependent sodium-potassium pump
Answer
The correct answer is the covalent attachment of ubiquitin to cytoskeletal proteins, which facilitates targeted protein degradation.
The patient's clinical presentation of muscle wasting after prolonged casting is a classic example of disuse atrophy. At the cellular level, atrophy is characterized by a reduction in the size of the cell to achieve a new equilibrium with a reduced workload or nutrient supply. This shrinkage is achieved through decreased protein synthesis and increased protein degradation. The primary mechanism for degrading intracellular proteins in this context is the ubiquitin-proteasome pathway. Nutrient deficiency or disuse activates ubiquitin ligases, which attach ubiquitin molecules to target cytoskeletal proteins. These 'tagged' proteins are then recognized and degraded by the proteasome.
Step-by-Step Solution
Key Concept
Disuse atrophy of skeletal muscle is a reversible cellular adaptation characterized by decreased cell size, primarily mediated by increased degradation of cytoskeletal proteins via the ubiquitin-proteasome pathway.